A Smarter Path for Dizziness: When and Why to Refer for Vestibular Therapy
-
By
-
May 18, 2026
-
6 min
By
May 18, 2026
A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.
April 23, 2026